Detalhe da pesquisa
1.
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.
Blood
; 142(8): 687-699, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390310